CAS No. |
156042-22-7 |
中文名称 |
2-[4,5-二羟基-2-[[12-羟基-17-[6-羟基-6-甲基-2-[(3,4,5-三羟基-6-(羟甲基)四氢-2H-吡喃-2-基)氧基]庚-4-烯-2-基]-4,4,8,10,14-五甲基十六氢-1H-环戊并[a]菲-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3-基]氧基]-6-(羟甲基)四氢-2H-吡喃-3,4,5-三醇 |
英文名称 |
2-((4,5-dihydroxy-2-((12-hydroxy-17-(6-hydroxy-6-methyl-2-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-4-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
别名 |
vina-ginsenoside R8;(3beta,12beta,23E)-20-(beta-D-Glucopyranosyloxy)-12,25-dihydroxydammar-23-en-3-yl 2-O-beta-D-glucopyranosyl-beta-D-glucopyranoside;β-D-Glucopyranoside, (3β,12β,23E)-20-(β-D-glucopyranosyloxy)-12,25-dihydroxydammar-23-en-3-yl 2-O-β-D-glucopyranosyl- |
标准英文名 |
2-((4,5-dihydroxy-2-((12-hydroxy-17-(6-hydroxy-6-methyl-2-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hept-4-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol |
MDL No. |
MFCD10566701 |
分子式 |
C48H82O19 |
分子量 |
963.16
|
精确分子量 |
962.55
|
SMILES |
CC(C)(O)C=CCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C3(C)CCC(OC4OC(CO)C(O)C(O)C4OC4OC(CO)C(O)C(O)C4O)C(C)(C)C3CCC12C |
标准SMILES |
CC(C)(O)C=CCC(C)(OC1OC(CO)C(O)C(O)C1O)C1CCC2(C)C1C(O)CC1C2(C)CCC2C1(C)CCC(OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O)C2(C)C |
用途 |
Vinaginsenoside R8 is an extract from ginseng leaves; it exhibits activity against ADP-induced platelet aggregation (IC50 = 25.18 μM). |
InChIKey |
IAEZLXLDZBZQPU-UHFFFAOYSA-N |